Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Enliven Therapeutics, Inc. (ELVN) position

Not anymore: Jim Simons fully exited ELVN in Q4 2025. The position peaked at an amount we cannot price in Q1 2023.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
59K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

ELVN price vs Simons's position

Dates
$50$52$54$56← Earlier —4 purchases, 1 sell
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q4 2025 Exited −59K −100.0% 0 Feb 12, 2026
Q3 2025 Added +35K +146.9% 59K Nov 13, 2025
Q2 2025 Added +12K +100.8% 24K Aug 13, 2025
Q1 2025 New +12K 12K May 14, 2025
Q2 2023 Reduced −34K −48.5% 36K Aug 11, 2023
Q1 2023 New +70K 70K May 12, 2023
Data through Q4 2025 · filed Feb 12, 2026
6 grouped rows from 6 quarters

More Simons positions

Common questions

Does Jim Simons own ELVN?

Not currently. Jim Simons fully exited ELVN in Q4 2025, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy ELVN?

Jim Simons first disclosed a ELVN position in Q1 2023; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell ELVN?

Yes. Jim Simons reduced and then fully exited ELVN by Q4 2025; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ELVN does Jim Simons own?

None as of the latest filing: Jim Simons has exited ELVN. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for ELVN?

Jim Simons began building the ELVN position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.